News | Page 4 | Loda Lab

Dr. Pederzoli attended the Human Tumor Atlas Network (HTAN) Data Jamboree at the NIH

November 15, 2024

Last week, Dr. Pederzoli attended the in-person Human Tumor Atlas Network (HTAN) Data Jamboree, organized in Bethesda by the NIH’s National Cancer Institute (November 6-8, 2024).

Dr. Pederzoli joined colleagues from a wide range of fields and communities to explore new approaches to analyze and integrate single-cell and spatial omics data from the HTAN. By participating in this event, he had the opportunity to learn...

Dr. Nuzzo received the EACR-AACR-The Mark Foundation for Cancer Research Award at the 35th Pezcoller Symposium

July 2, 2024

On June 24-25 2024, the Loda Lab participated in the 35th Pezcoller Symposium held in Trento (Italy). The symposium focused on "Cancer as a Systemic Disease: Interaction between Tumor and Host," a topic of critical importance in contemporary cancer research.

The Pezcoller Symposium, renowned for its contributions to the field of cancer research, is a cornerstone event that brings together leading scientists and researchers from around the world. This year's symposium was chaired by the...

Dr. Rodrigues presented her research at the New York Prostate Club

June 11, 2024

Our postdoctoral associate, Dr. Silvia Daniele Rodrigues, presented her work during a meeting of the New York Prostate Club on June 5, 2024. In her talk, titled "Disrupting ELOVL5 Function Impairs Prostate Cancer Progression in c-Myc-driven Mouse Models", Dr. Rodrigues discussed about her crucial work to understand the interplay between lipogenesis, lipid elongation and prostate cancer progression. To this end, Dr. Rodrigues generated genetically engineered mouse models (GEMM) with deletion...